In the Wegovy clinical trials, roughly 22% of participants reported symptoms of the common cold, compared to a lower percentage in the placebo group
Purpose-built for physicians GLP-1s hold promise in MS, but more rigorous examination is required Key takeaways: There is limited evidence of GLP-1 receptor agonist safety and efficacy in MS
Quick Facts: Higher doses (e.g., semaglutide 7.2 mg) showed up to 25% weight loss in trials
Products such as the Eqoq Tablet 10s may help by providing antioxidant support that slows melanin production from within
In another study, 500 mg of berberine three times per day caused an average of 5 pounds of weight loss over 12 weeks
If youre noticing patterns that concern you, reviewing common ADHD symptoms can help you understand whether what youre seeing warrants its own evaluation, entirely separate from anything related to a weight management medication